🇺🇸 Amoxanox in United States

FDA authorised Amoxanox on 17 December 1996

Marketing authorisations

FDA — authorised 17 December 1996

  • Application: NDA020511
  • Marketing authorisation holder: ULURU
  • Local brand name: APHTHASOL
  • Indication: PASTE — DENTAL
  • Status: approved

Read official source →

FDA — authorised 29 September 2004

  • Application: NDA021727
  • Marketing authorisation holder: ULURU
  • Local brand name: AMLEXANOX
  • Indication: PATCH — TOPICAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Amoxanox in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Amoxanox approved in United States?

Yes. FDA authorised it on 17 December 1996; FDA authorised it on 29 September 2004; FDA has authorised it.

Who is the marketing authorisation holder for Amoxanox in United States?

ULURU holds the US marketing authorisation.